Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: resembling (46)

Paclitaxel (21 day)

Description: Chemotherapy Protocol BREAST CANCER PACLITAXEL (21day) Regimen • Breast Cancer – Paclitaxel (21day) Indication • Treatment of locally advanced or metastatic breast cancer that
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-21-day.pdf

Letrozole-Ribociclib

Description: Chemotherapy Protocol Breast Cancer Letrozole-Ribociclib Regimen • Breast Cancer – Letrozole-Ribociclib Indication • Ribociclib in combination with an aromatase inhibitor is indicated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Letrozole-Ribociclib.pdf

Letrozole-Palbociclib

Description: Chemotherapy Protocol Breast Cancer Letrozole-Palbociclib Regimen • Breast Cancer – Letrozole-Palbociclib Indication • Palbociclib in combination with an aromatase inhibitor is indicated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Letrozole-Palbociclib.pdf

Kadcyla (Trastuzumab emtansine) v1

Description: Chemotherapy Protocol BREAST CANCER KADCYLA (trastuzumab emtansine) Kadcyla (trastuzumab emtansine) is NOT the same drug as Herceptin (trastuzumab). There is considerable
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Kadcyla-Trastuzumab-emtansine-v1.pdf

Fulvestrant-Palbociclib

Description: Chemotherapy Protocol Breast Cancer Fulvestrant-Palbociclib Regimen • Breast Cancer – Fulvestrant-Palbociclib Indication Palbociclib with fulvestrant is recommended for use within the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Fulvestrant-Palbociclib.pdf

Exemestane-Ribociclib

Description: Chemotherapy Protocol Breast Cancer Exemestane-Ribociclib Regimen • Breast Cancer – Exemestane-Ribociclib Indication • Ribociclib in combination with an aromatase inhibitor is indicated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Exemestane-Ribociclib.pdf

Exemestane-Palbociclib

Description: Chemotherapy Protocol Breast Cancer Exemestane-Palbociclib Regimen • Breast Cancer – Exemestane-Palbociclib Indication • Palbociclib in combination with an aromatase inhibitor is indicated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Exemestane-Palbociclib.pdf

Everolimus-Exemestane

Description: Regimen Chemotherapy Protocol BREAST CANCER EVEROLIMUS and EXEMESTANE • Breast Cancer – Everolimus-Exemestane Indication • The first or second line treatment of post
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Everolimus-Exemestane.pdf

Docetaxel (75) Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER DOCETAXEL (75) Regimen Breast Cancer – Docetaxel (75) Indication Treatment of locally advanced or metastatic HER2 positive breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-75-Ver-11.pdf

Docetaxel (100) Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER Regimen DOCETAXEL (100) Breast Cancer – Docetaxel (100) Indication Neoadjuvant / adjuvant treatment of breast cancer WHO Performance status
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-100-Ver-11.pdf

511 to 520 of 757

Previous … 50 51 52 53 54 … Next